These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 18060184)

  • 1. The aspects of angiogenesis in anal canal carcinomas compared with that in colorectal carcinomas.
    Gurzu S; Jung J; Azamfirei L; Mezei T; Cîmpean AM
    Rom J Morphol Embryol; 2007; 48(4):349-53. PubMed ID: 18060184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differences between the endothelial area marked with CD31 and CD105 in colorectal carcinomas by computer-assisted morphometrical analysis.
    Jung I; Gurzu S; Raica M; Cîmpean AM; Szentirmay Z
    Rom J Morphol Embryol; 2009; 50(2):239-43. PubMed ID: 19434317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer.
    Gao J; Knutsen A; Arbman G; Carstensen J; Frånlund B; Sun XF
    Dig Liver Dis; 2009 Feb; 41(2):116-22. PubMed ID: 19038587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The angiogenesis in colorectal carcinomas with and without lymph node metastases.
    Gurzu S; Jung J; Azamfirei L; Mezei T; Cîmpean AM; Szentirmay Z
    Rom J Morphol Embryol; 2008; 49(2):149-52. PubMed ID: 18516319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count.
    Romani AA; Borghetti AF; Del Rio P; Sianesi M; Soliani P
    J Surg Oncol; 2006 May; 93(6):446-55. PubMed ID: 16615157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival.
    Bendardaf R; Buhmeida A; Hilska M; Laato M; Syrjänen S; Syrjänen K; Collan Y; Pyrhönen S
    Anticancer Res; 2008; 28(6B):3865-70. PubMed ID: 19192642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival.
    Lazăr D; Tăban S; Ardeleanu C; Simionescu C; Sporea I; Cornianu M; Vernic C
    Rom J Morphol Embryol; 2008; 49(3):371-9. PubMed ID: 18758643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.
    Lazăr D; Tăban S; Raica M; Sporea I; Cornianu M; Goldiş A; Vernic C
    Rom J Morphol Embryol; 2008; 49(2):137-48. PubMed ID: 18516318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counting of angiogenesis in colorectal carcinomas using double immunostain.
    Gurzu S; Cimpean AM; Kovacs J; Jung I
    Tumori; 2012; 98(4):485-90. PubMed ID: 23052166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of desmoplasia in recurrence of stage II colorectal cancer within five years after surgery and therapeutic implication.
    Crispino P; De Toma G; Ciardi A; Bella A; Rivera M; Cavallaro G; Polistena A; Fornari F; Unim H; Pica R; Cassieri C; Mingazzini PL; Paoluzi P
    Cancer Invest; 2008 May; 26(4):419-25. PubMed ID: 18443963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
    Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
    Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal carcinoma: correlation between age, gender and subsite distribution.
    Efremidou EI; Liratzopoulos N; Papageorgiou SM; Romanidis K; Tourlis T; Kouklakis G; Manolas KJ
    Chirurgia (Bucur); 2008; 103(6):659-63. PubMed ID: 19274910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
    Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
    Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of VEGF, CD105, and CD31 in the Prognosis of Colorectal Cancer Cases.
    Mohamed SY; Mohammed HL; Ibrahim HM; Mohamed EM; Salah M
    J Gastrointest Cancer; 2019 Mar; 50(1):23-34. PubMed ID: 29110224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
    Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
    Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of cytoskeleton regulatory protein Mena in colorectal lesions.
    Gurzu S; Jung I; Prantner I; Ember I; Pávai Z; Mezei T
    Rom J Morphol Embryol; 2008; 49(3):345-9. PubMed ID: 18758639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of right-sided colorectal cancer after breast cancer: a population-based study.
    Tang LY; Nugent Z; Demers AA; Singh H
    Am J Gastroenterol; 2009 May; 104(5):1213-20. PubMed ID: 19319130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry.
    Iwata T; Miyata Y; Kanda S; Nishikido M; Hayashi T; Sakai H; Kanetake H
    Urology; 2008 Apr; 71(4):749-54. PubMed ID: 18295862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of angiogenesis in soft-tissue tumors.
    Baneth V; Raica M; Cîmpean AM
    Rom J Morphol Embryol; 2005; 46(4):323-7. PubMed ID: 16688371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation.
    Rupertus K; Dahlem C; Menger MD; Schilling MK; Kollmar O
    Ann Surg Oncol; 2009 Sep; 16(9):2629-37. PubMed ID: 19551445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.